NEUPHORIA THERAPEUTICS INC (NEUP) Stock Income Statement
NASDAQ:NEUP - US64136E1029 - Common Stock
13.92 USD
-1.18 (-7.78%)
| TTM (2025-3-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.66M | 22.10K | 169.90K | 0.00 | 30.10K | |||
| Operating Expenses | 28.85M | 32.98M | 14.52M | 5.59M | 2.67M | |||
| Research and Development | 14.67M | 19.61M | 10.31M | 3.71M | 3.75M | |||
| Selling, General, and Administrative Expenses | 14.18M | 13.01M | 7.34M | 4.68M | 4.05M | |||
| Operating Income | -13.19M | -32.96M | -14.35M | -5.59M | -2.64M | |||
| Interest Income/Expense | 612.20K | 909.00K | 218.50K | -56.20K | -1.52M | |||
| Other Income/Expense | 5.31M | N/A | -11.10K | -173.70K | -33.60K | |||
| Non Recurring Items | N/A | N/A | 0.00 | 110.50K | 198.20K | |||
| Income Before Taxes | -7.27M | -32.05M | -14.14M | -5.72M | -3.88M | |||
| Income Tax | -289.10K | -206.80K | -123.60K | -120.80K | -133.80K | |||
| Net Income | -6.98M | -31.85M | -14.02M | -5.60M | -4.59M | |||
| EBITDA | -12.03M | -32.30M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 5.21 | -0.26 | -0.12 | -0.09 | -0.08 | |||
| Non GAAP EPS | N/A | N/A | -0.02 | -0.01 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -44.55% | -144104.07% | -8251.68% | N/A | -15236.88% | |||
| Operating Profit Margin | -84.19% | -149152.49% | -8445.79% | N/A | -8774.09% | |||
All data in USD